[ad_1]
Ilan Danieli, CEO of Precipio Inc. (NASDAQ: PRPO), told Proactive Investors that the Connecticut-based diagnostics company is expanding internationally with its pathology services.
Danieli said that the company, aged eight, is already in talks with the world's leading health care systems, focusing first on Asia, South America, Europe and the Middle East. In the past month, Precipio's stock has more than doubled and Danieli said he believed the market was starting to realize the value of the company.
Source link
